Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2771-2784
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2771
Figure 2
Figure 2 Characteristics of the study participants. Mean concentrations of (A) glycosylated hemoglobin (HbA1c); (B) fasting blood glucose (FBG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), total cholesterol (TC); (C) alanine aminotransferase (ALT), and aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), and alpha-fetoprotein (AFP); and (D) total bilirubin (TBil) and direct bilirubin (DBil) in the non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and healthy control groups. E: Results of ultrasound examination in the three groups. Significant differences among the three groups were assessed by one-way ANOVA in A-D and by t-tests in E. aP < 0.05, bP < 0.01 vs the control group; cP < 0.05, dP < 0.01 vs the NAFLD group.